<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02272842</url>
  </required_header>
  <id_info>
    <org_study_id>808734</org_study_id>
    <secondary_id>U1111-1161-5187</secondary_id>
    <nct_id>NCT02272842</nct_id>
  </id_info>
  <brief_title>Vitamin B12, Neurodevelopment and Growth in Nepal</brief_title>
  <acronym>BeLive</acronym>
  <official_title>The Effect of Vitamin B12 Supplementation in Nepali Infants on Growth and Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre For International Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tribhuvan University, Nepal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uni Health, Uni Research, Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre For International Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Globally, vitamin B12 deficiency is one of the most common micronutrient
      deficiencies. The only relevant source of Vitamin B12 is animal-source foods. Vitamin B12 is
      crucial for normal cell division and is necessary for brain growth as well as for the
      maintenance of its normal function. Deficiency is also associated with impaired growth. In a
      previous study, we demonstrated that vitamin B12 administration over a period of six months
      enhanced growth, and scores on a neuro-developmental test in young Indian children. However,
      the overall effect was small and, for the developmental scores significant only in those that
      were malnourished at the start of the study.

      Our findings need to be verified in trials targeting younger, malnourished children and with
      longer supplementation time.

      Hypothesis: This proposed study will test three hypotheses; to measure to what extent 2
      recommended daily allowances (RDA) of vitamin B12 administration for one year to stunted
      children improves; 1) growth, 2) neurodevelopment, and 3) hemoglobin concentration.

      Study design: Randomized placebo-controlled trial. Half of the children will receive a paste
      containing vitamin B12, the other half the same paste but without vitamin B12.

      Study participants and site: 600 malnourished infants in Bhaktapur municipality in Nepal. In
      this population we have demonstrated that vitamin B12 deficiency and poor growth is common in
      early childhood.

      Intervention: Daily administration of a paste containing vitamin B12 or placebo for 12 months

      Data: The main outcomes of this study are scores on developmental assessments tools and
      growth measured every month for 12 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Scientific basis: Globally, vitamin B12 deficiency is one of the most common micronutrient
      deficiencies. The only relevant source of vitamin B12 is animal-source foods. Vitamin B12 is
      crucial for normal cell division and differentiation and is necessary for the development and
      initial myelination of the central nervous system as well as for the maintenance of its
      normal function. Deficiency is also associated with impaired infant and child growth.

      In a previous clinical trial, we demonstrated that vitamin B12 administration over a period
      of six months enhanced growth and neurodevelopment in young Indian children. The overall
      effect on growth was significant but small. We saw an effect on both ponderal (weight for age
      z scores) and linear (height for age z scores) growth. However, the overall effects were
      driven by the effects in the subgroups of children who were wasted, underweight or stunted at
      baseline, and no effect in the children who were not malnourished at baseline. This effect
      modification was significant for all three (stunting, wasting, and underweight) baseline
      variables. Similarly, the effect of the intervention on neurodevelopmental scores was also
      strongest in the subgroup of children that were stunted.

      We have for the last 15 years undertaken studies on dietary intake and status in women and
      children in Bhaktapur, Nepal. In this site, vitamin B12 deficiency is very common. The
      objective of the proposed study is to measure to what extent administration of 2 RDA of
      vitamin B12 to stunted children from the last half of infancy and for 12 months affect
      neurodevelopment, growth and hemoglobin concentration.

      Hypothesis: Daily supplementation of 2 RDA of vitamin B12 in young Nepali children for 12
      months improves neurodevelopment, growth and hemoglobin concentration.

      Study design: Individually randomized placebo controlled, double blind trial. Children will
      be identified in the community and stunted children will be randomized to daily receive a
      paste containing vitamin B12 or a placebo paste. The paste will be delivered by trained field
      workers every day and by the caregivers on Saturdays and public holidays.

      Study participants and site: 600 stunted children aged 6 to 11 months in Bhaktapur
      municipality and surrounding areas.

      Intervention: Daily administration of a paste containing vitamin B12 or placebo for 12
      months.

      Comparator: Placebo, identical to the vitamin B12 supplements.

      Data: Primary outcomes: (i) neurodevelopmental scores measured by Bayley Scales of Infant and
      Toddler Development 3rd edition and the Ages and Stages Questionnaire 3rd edition after 6 and
      12 months of supplementation (ii) growth measured by change in height for age, weight for age
      and weight for height z-score from study start to end study and growth velocity z scores
      during the six first and six last months of supplementation (iii) hemoglobin concentration
      after 12 months of supplementation. Secondary: (i) cognitive development in children measured
      approximately 3 and 6 years after enrollment, (ii) linear and ponderal growth measured 2 and
      3 years after enrollment, (iii) hemoglobin concentration measured 2 and 3 years after
      enrollment. All secondary outcomes require additional funding.

      Relevance for programs and public health: Improved learning ability and growth in young
      malnourished children. If the supplementation is effective this will have consequences for
      dietary recommendation to malnourished children worldwide. In contrast to most other relevant
      nutritional interventions, vitamin B12 is inexpensive and our body has the ability to store
      vitamin B12, up to years. Thus, improving the status of this nutrient for a limited time
      period may have impact on learning and productivity beyond the time of administration and
      help to lift poor children out of the vicious cycle of poverty and malnutrition.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 20, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurodevelopment</measure>
    <time_frame>12 months</time_frame>
    <description>Neurodevelopment measured by the Bayley Scales of Infant Development version 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Growth</measure>
    <time_frame>12 months</time_frame>
    <description>Change in weigh for age and length for age z scores from study start to end study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin concentration</measure>
    <time_frame>12 months</time_frame>
    <description>Change in hemoglobin concentration from baseline to end study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Growth velocity over the first six months of supplementation</measure>
    <time_frame>6 months</time_frame>
    <description>length and weight growth velocity z scores the first 6 months of supplementation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictors for neurodevelopment in young Nepali children</measure>
    <time_frame>12 months</time_frame>
    <description>Using the collected data, identify morbidity, stimulation, nutrition, socioeconomic related predictors for neurodevelopment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identify subgroups of children who benefit from vitamin B12 supplementation</measure>
    <time_frame>12 months</time_frame>
    <description>Based on selected baseline variables we will identify subgroups who benefit from vitamin B12 supplementation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effect of vitamin B12 supplementation on markers of vitamin B status</measure>
    <time_frame>12 months</time_frame>
    <description>We will draw a blood sample at study start and at end study to measure to what extent vitamin status is altered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopment measured by other tools.</measure>
    <time_frame>12 months</time_frame>
    <description>We will measure to what extent vitamin B12 supplementation improves neurodevelopment measured by other tools such as the Ages and Stages Questionnaire (version 3) and the NEPSY II test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate adverse effects of the intervention</measure>
    <time_frame>12 months</time_frame>
    <description>We will investigate side effects such as pain, nausea, vomiting, regurgitation, allergic reactions and others after each dose of the intervention.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Extended followup: Neurodevelopment</measure>
    <time_frame>3 years</time_frame>
    <description>If resources allow, we will follow the cohort beyond the planned (and funded) project period and measure neurodevelopment using appropriate tests such as the Wechsler tests</description>
  </other_outcome>
  <other_outcome>
    <measure>Surrogate markers for Neurodevelopment</measure>
    <time_frame>2 years</time_frame>
    <description>If funding allows, measure other markers related to neurodevelopment such as Brain Derived Neurotrophic Factor</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Development</condition>
  <condition>Vitamin Deficiency</condition>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Vitamin B12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A paste containing vitamin B12 2Âµg per 10 mL administered every day. The paste also contains 1 RDA of several other vitamins. The paste is produced by Compact (Norway / India)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A paste containing no vitamin administered every day. The paste also contains 1 RDA of several vitamins, but no vitamin B12. The paste is produced by Compact (Norway / India)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin B12</intervention_name>
    <description>Vitamin B12 in a multivitamin paste.</description>
    <arm_group_label>Vitamin B12</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Cobalamin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 6 to 11 months

          -  Stunted

          -  Availability of informed verbal consent

          -  Plan to reside in the area for the next 12 months

        Exclusion Criteria:

          -  Severe systemic illness requiring hospitalization

          -  Severe malnutrition, i.e. weight for height &lt; -3 z of the WHO standard for this age
             group. For ethical reasons these children require micronutrient supplementation and
             adequate medical care.

          -  Lack of consent

          -  Taking B vitamin supplements that include vitamin B12.

          -  Severe anemia (Hb &lt; 7 g/dL). This would be a temporary exclusion and the children will
             be enrolled if they are successfully treated.

          -  Ongoing acute infection with fever or infection that requires medical treatment. This
             would be a temporary exclusion and the children will be enrolled after recovery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>11 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prakash S Shrestha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tribhuvan University, Nepal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sudha Basnet, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tribhuvan University, Nepal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tor A Strand, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Innlandet Hospital Trust / University of Bergen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Siddhi Memorial Hospital (SMH),Bhelukhel, Bhimsensthan</name>
      <address>
        <city>Bhaktapur</city>
        <zip>P.O.Box 40</zip>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <link>
    <url>https://www.thrasherresearch.org/SitePages/current-grants-all.aspx</url>
    <description>Link to the founding source.</description>
  </link>
  <reference>
    <citation>Taneja S, Strand TA, Kumar T, Mahesh M, Mohan S, Manger MS, Refsum H, Yajnik CS, Bhandari N. Folic acid and vitamin B-12 supplementation and common infections in 6-30-mo-old children in India: a randomized placebo-controlled trial. Am J Clin Nutr. 2013 Sep;98(3):731-7. doi: 10.3945/ajcn.113.059592. Epub 2013 Jul 31.</citation>
    <PMID>23902779</PMID>
  </reference>
  <reference>
    <citation>Strand TA, Taneja S, Ueland PM, Refsum H, Bahl R, Schneede J, Sommerfelt H, Bhandari N. Cobalamin and folate status predicts mental development scores in North Indian children 12-18 mo of age. Am J Clin Nutr. 2013 Feb;97(2):310-7. doi: 10.3945/ajcn.111.032268. Epub 2013 Jan 2.</citation>
    <PMID>23283502</PMID>
  </reference>
  <reference>
    <citation>Black MM. Effects of vitamin B12 and folate deficiency on brain development in children. Food Nutr Bull. 2008 Jun;29(2 Suppl):S126-31. Review.</citation>
    <PMID>18709887</PMID>
  </reference>
  <reference>
    <citation>Black MM. Micronutrient deficiencies and cognitive functioning. J Nutr. 2003 Nov;133(11 Suppl 2):3927S-3931S. doi: 10.1093/jn/133.11.3927S. Review.</citation>
    <PMID>14672291</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2014</study_first_submitted>
  <study_first_submitted_qc>October 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2014</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nepal</keyword>
  <keyword>Cobalamin</keyword>
  <keyword>Neurodevelopment</keyword>
  <keyword>Stunting</keyword>
  <keyword>Growth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Avitaminosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

